News and Events

Noteworthy developments & upcoming engagements in the global scientific community.

News

ACEA Biosciences Partners with the Cancer Research Institute in Support of Cancer Immunotherapy Month

To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite … Continued

New High Performance 4-Laser Benchtop Flow Cytometer to be Launched by ACEA Biosciences at CYTO 2018

The NovoCyte Quanteon™ flow cytometer, a highly advanced benchtop instrument with 4 lasers and 25-color options, will be launched at … Continued

Novel Assay Monitors Kinetics of Cell Migration in High Throughput Format

While new AccuWound tool generates 96 identical scratch wounds in just seconds, wound healing is subsequently monitored in real-time by … Continued

ACEA Biosciences Hosted Cancer and Immunotherapy Symposium for Leading Scientists in T Cell Therapy

Researchers worldwide participated in the 6th Annual Cancer Immunotherapy Symposium to learn groundbreaking new methods for CAR-T cell and TCR … Continued

Physiologically Relevant Testing of Cancer Immunotherapies Now Possible with Real-Time Potency Assay

Automated monitoring of cancer cell viability reveals complex interaction with immune cells and effector molecules, enabling rapid testing of immunotherapies. … Continued

xCELLigence-based Cardiotoxicity Study Voted Paper of the Year

AstraZeneca’s in vitro analysis of kinase inhibitor-induced cardiotoxicity receives Drug Discovery Toxicology Paper of the Year Award At last week’s … Continued

Live Cell Analysis Using xCELLigence Instruments: Searchable Library of Over 1,400 Publications Now Online

ACEA Biosciences makes available an exhaustive library of xCELLigence papers spanning 15 years and applications ranging from immune cell killing … Continued

Real-Time Monitoring of Cancer Cells Under Hypoxic Conditions Reveals Novel Regulator of Proliferation and Migration

Employing an xCELLigence Real-Time Cell Analysis instrument, Korean scientists demonstrate that within a hypoxic environment the hYSK1 protein negatively regulates … Continued

Real-Time Monitoring of Melanoma Cell Invasion Helps Scientists Elucidate Key Regulators of Metastasis

Using xCELLigence assay, the interaction between two membrane proteins is shown to modulate the trans-endothelial migration of metastatic cells A … Continued

Viral Vaccine Development Gets Major Boost From xCELLigence RTCA

Using xCELLigence Real-Time Cell Analysis (RTCA), Sanofi Pasteur scientists have developed an assay for accurate viral titer determination that is … Continued

Asthma Intervention: Novel Impedance-Based Assay Monitors the Contraction and Relaxation of Smooth Muscle Cells and Fibroblasts in Real-Time

Using xCELLigence Real-Time Cell Analysis (RTCA) scientists at Genentech have developed an automated and high throughput assay for studying the molecular … Continued

Oncolytic Adenovirus Expressing BiTE Effectively Recruits T Cells to Kill Diverse Cancer Cell Types

By expressing a secreted form of an EpCAM-specific BiTE molecule in the cancer cells it infects, a novel oncolytic virus … Continued

ACEA Biosciences and Ncardia announce global partnership to provide solutions for cardiac drug discovery and cardiac safety assessment

ACEA Biosciences (ACEA), a pioneer and leader in label-free real-time cell analysis instrumentation, and Ncardia, a leading expert in human … Continued

Characterizing Bacteriophage-Derived Enzymes That Degrade Staphylococcus Biofilms

Employing the xCELLigence® technology from ACEA Biosciences, a team of Spanish scientists have developed a real-time assay for screening anti-biofilm … Continued

Pluriomics BV Announced Cooperation with ACEA Biosciences to Advance Cardiovascular Drug Discovery and the Expansion of its Services Portfolio

Leiden, The Netherlands, August 21, 2017. Pluriomics and ACEA Biosciences (ACEA) today announced a cooperation to advance together cardiac drug … Continued

ACEA Biosciences Announces Collaboration with Memorial Sloan Kettering Cancer Center on Personalized CAR T Cell Therapy

MSK and ACEA will evaluate whether patient-specific ex-vivo cancer immunotherapy assays are predictive of in vivo efficacy. ACEA Biosciences and … Continued

ACEA Biosciences Introduces a Multi-Option Configuration NovoCyte® Flow Cytometer

ACEA Biosciences continues to innovate and improve its already flexible and easy to use NovoCyte Flow Cytometry system by developing … Continued

Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around the World

Researchers from academia, industry, and federal agencies convened in Washington, D.C. this week to discuss recent progress in diverse areas … Continued

Recipients of ACEA Bioscience’s Travel Award Announced for Winter 2017

ACEA congratulates Dr. Calum Robb and Dr. Rentian Wu for winning the Winter 2017 Research Travel Award. ACEA Biosciences, a … Continued

Endocrine Disrupting Chemicals Identified Using xCELLigence® Real-Time Cell Analysis

ACEA Biosciences develops novel assay for the rapid and facile detection of agonists and antagonists of key endocrine receptors. Endocrine-disrupting … Continued

ACEA Biosciences Hires Roger Luo as Vice President of Global Clinical Development

San Diego biotech recruits expertise from Johnson & Johnson to help oversee global clinical trials of its lung cancer drug … Continued

TechNews: Biotechniques January 2017 issue features Dr. Xiaobo Wang

Biotechniques January 2017 issue features Dr. Xiaobo Wang, Chief Technology Officer at ACEA Biosciences, in the Tech News article – … Continued

ACEA Biosciences Announces Winners of its Travel Award

San Diego-based biotechnology company awards funding to researchers in the fields of cardiotoxicity and prostate cancer drug discovery. ACEA Biosciences, … Continued

Monitoring the Formation and Removal of Biofilms From Clinically Relevant Pathogens in Real-Time

Spanish scientists demonstrate that the growth and destruction of medically important bacterial biofilms can be quantitatively monitored in real-time using … Continued

WEBINAR – Flow Cytometry: Emerging Instrumentation and Application Trends | Wed, Feb 15, 2017

Join us for our webinar on Wednesday, February 15, 2017 at 11 AM EST / 8 AM PST / 4 PM … Continued

Using Cell Signaling Activity, Rather Than Biomarkers, to Determine the Optimal Therapeutic Regimen for Breast Cancer Patients

Using ACEA Bioscience instruments, scientists at the University of Minnesota demonstrated that a functional assay of patient derived tumor cells … Continued

ACEA Biosciences Presents Efficacy and Safety Data From AC0010 Phase I/II Clinical Trial for Treatment of Advanced Non-Small Cell Lung Cancer at the WCLC 2016 Conference

Novel EGFR tyrosine kinase inhibitor AC0010 displays high efficacy, tolerability, and safety in phase I/II clinical trials. ACEA Biosciences, Inc. … Continued

ACEA Biosciences Announces Data Presentation at WCLC 2016 Conference: New AC0010 Data to Be Presented

Clinical trial results for novel EGFR inhibitor AC0010 will be presented December 7th at World Conference on Lung Cancer. ACEA … Continued

ACEA Biosciences Appoints Li Xu, M.D. as Chief Medical Officer

Former Vice President and Head of the Oncology Business Unit at Jiangsu Hengrui Medicine assumes position as Chief Medical Officer … Continued

Monitoring in Real Time the Formation and Removal of Biofilms From Clinically Relevant Pathogens

Spanish scientists demonstrate that the growth and destruction of medically important bacterial biofilms can be quantitatively monitored in real-time using … Continued

xCELLigence Instruments From ACEA Biosciences Honored With “Premier Cell Analysis Instrument” Award for 2016

For their ability to quantitatively monitor – in a label-free manner – cell number, morphology, and adhesion strength for a … Continued

Scientists At University Hospital In Basel Demonstrate Practical Step Towards Personalizing Cancer Therapy

Cancer consists of >100 distinct diseases that manifest in ~200 cell types with diverse genetic/mutational etiologies. For the clinician this … Continued

ACEA Biosciences Launches NovoCyte® Yellow (561nm) Laser Systems

With the addition of a 561nm laser to its NovoCyte cytometers, ACEA Biosciences expands its product configuration capabilities. The two … Continued

Study of Anthracycline-Induced Cardiotoxicity Using xCELLigence® Cardio Instrument Earns Top Honors

For her investigations into the mechanisms by which angiotensin signaling modulators reduce anthracycline-induced cardiotoxicity, Kim Rockley – a graduate student … Continued

Cancer Immunotherapy Webinar by Dr. Nabil Ahmed on October 20, 2016 (8:00 AM PST)

Join us for our Cancer Immunotherapy-focused Webinar with Dr. Nabil Ahmed of Baylor College of Medicine on Thursday, October 20, … Continued

Researcher at the Free University of Brussels in Belgium Receives the 2016 xCELLigence Research Grant from ACEA Biosciences

Worldwide nearly 10 million new cases of mycobacterium tuberculosis (TB) are diagnosed each year, leading to 1.5 million deaths. Despite … Continued

Researchers at Baylor College of Medicine Publish Paper that Demonstrate that CAR-T Cells with Dual Antigen Specificity Display Improved Efficacy Against Glioblastoma

Even when they are composed of the same types of cells, tumors located in different regions of a person’s body … Continued

Studying Viruses in Real-Time

Determining virus titers and tracking virus growth via traditional cytopathic effect assays is labor intensive and produces only endpoint data.  … Continued

ACEA Biosciences Hosts UCSD Postdocs for Exposure to Industry Program

  On Thursday June 23, 2016 ACEA Biosciences hosted postdoctoral fellows from UC San Diego’s Exposure to Industry Program (EIP), … Continued

ACEA Biosciences Introduces an Immunotherapy Kit for Monitoring and Quantifying the Potency of B Cell Killing

Label-Free Immune Cell Mediated Killing Kinetics and Potency Analysis in Real-Time   ACEA Biosciences, a pioneer in the development of … Continued

ACEA Biosciences Brings Together Leaders in Cancer and Immunotherapy Research

With the goal of highlighting recent breakthroughs and emerging trends in cancer and immunotherapy research, ACEA Biosciences hosted its 4th … Continued

Winter 2016 Research Travel Award Winner

ACEA Biosciences would like to congratulate Dr. Farah Sheikh, an associate professor in the Department of Medicine at the University of … Continued

Fall 2015 Research Travel Award Winner

We would like to congratulate James Murray, a doctoral student under Dr. James Murphy in the Mitochondrial Biology & Radiation Research … Continued

Summer 2015 Research Travel Award Winners

We would like to congratulate Hannah Yong, a doctoral student in the Perinatal Medicine Pregnancy Research Centre at The Royal Women’s … Continued

Using Cellular Impedance to Tackle Parasites

The frustration of staring down a microscope to count the number of times a worm wiggles has inspired an innovative … Continued

ACEA Biosciences, Inc. Awards the 2015 iCELLigence Research Grant to Christian Owusu

October 15, 2015, SAN DIEGO, California – ACEA Biosciences, Inc. (ACEA) has awarded Christian Owusu, a Ph.D. candidate at the … Continued

ACEA Biosciences Announces the Successful Completion of 30 Million USD in Venture Funding

ACEA Biosciences looks to its future with investments from Lilly Asia Ventures and Qiming Venture Partners. ACEA Biosciences, Inc., a … Continued

ACEA Biosciences, Inc. Welcomes Lincoln C. Muir

FOR IMMEDIATE RELEASE March 16, 2015 SAN DIEGO, California – ACEA Biosciences, Inc., a pioneer in the development and commercialization … Continued

ACEA Supports Young Cancer Researchers with the iCELLigence Innovative Research Grant

FOR IMMEDIATE RELEASE February 20, 2014   San Diego, CA – To further support cancer research progression, ACEA has installed … Continued

Michael Honeysett Appointed as Vice President of Global Commercialization

FOR IMMEDIATE RELEASE February 2, 2015 SAN DIEGO, California – ACEA Biosciences, Inc., a pioneer in the development and commercialization … Continued

ACEA Biosciences and Hurel® Corporation Announce Joint Marketing of Integrated Product Kits

––FOR IMMEDIATE RELEASE–– ACEA Biosciences and Hurel® Corporation Announce Joint Marketing of Integrated Product Kits Alliance to offer customers the … Continued

ACEA Biosciences, Inc. Awards Yale University Researcher the iCELLigence Research Grant

FOR IMMEDIATE RELEASE September 29, 2014   ACEA Biosciences, Inc. Awards Yale University Researcher the iCELLigence Research Grant   September … Continued

ACEA Biosciences Introduces the xCELLigence® RTCA CardioECR System

FOR IMMEDIATE RELEASE September 4, 2014 ACEA Biosciences Introduces the xCELLigence® RTCA CardioECR System First Platform with Simultaneous Measurement of … Continued

Introducing the all NEW xCELLigence CardioECR System: Measure Cardiomyocyte Contractility…

INTRODUCING THE ALL NEW xCELLigence CardioECR System Dual readout using impedance and field potential recording electrodes under pacing or non-pacing … Continued

ACEA Biosciences Introduces the NovoCyte™ Flow Cytometer

ACEA Biosciences Introduces the NovoCyte™ Flow Cytometer Exceptional Performance at a Low Investment Up to Fifteen Parameter Detection with Enhanced … Continued

ACEA Biosciences Offers Scientists Cost Savings With the New E-Plate View PET Product Line

San Diego, CA – ACEA Biosciences, Inc. the manufacturer and developer of xCELLigence® Real-Time Cellular Analysis (RTCA) instruments, is excited … Continued

Dr. Biao Xi, Principal Scientist at ACEA Biosciences receives the 2014 JALA Authors Choice Award for His Study on Preclinical Cardiac Safety Assessment

FOR IMMEDIATE RELEASE February 18, 2014   Dr. Biao Xi, Principal Scientist at ACEA Biosciences receives the 2014 JALA Authors … Continued

Global xCELLigence User Symposium Series for 2014

ACEA Biosciences, Inc. Announces its Global xCELLigence User Symposium Series for 2014 San Diego, CA – Based off of success … Continued

ACEA Biosciences Is the Recipient of a SBIR Award from EPA to Develop Sensitive Cell-based Detection Systems for Environmental Toxicants

ACEA Biosciences Is the Recipient of a SBIR Award from EPA to Develop Sensitive Cell-based Detection Systems for Environmental Toxicants … Continued

ACEA BIOSCIENCES SELECTED FOR IRS QUALIFYING THERAPEUTIC DISCOVERY GRANT

ACEA Biosciences, with headquarters in San Diego, California, is pleased to announce that it has been selected to receive a … Continued

Acquisition of the xCELLigence RTCA Cardio System by FDA

     San Diego – ACEA Biosciences announced today that the United States Food and Drug Administration (FDA) has acquired the xCELLigence … Continued

ACEA Biosciences Announces that the company has developed the iPad Compatible iCELLigence System

San Diego, California- ACEA Biosciences, Inc (San Diego), the developer and manufacturer of the xCELLigence System, announced that the company … Continued

xCELLigence System Evaluated in EU Project to Replace Animal Experiments in Cosmetics Industry

       ACEA and Roche’s xCELLigence RTCA System, developed and manufactured by ACEA Biosciences, Inc., and marketed by Roche, is … Continued

ACEA Biosciences, Inc. Announces New Patent; Broad ClaiGranted for Cytotoxicity Profiling and Chemical Compound Testing

San Diego, California (February 7, 2011) ACEA Biosciences, Inc., a pioneer in the development of high-performance microelectronic systems for cell-based … Continued

Quantitative Assessment of Clostridium Difficile Toxin by Real Time Cell Analysis

Quantitative Assessment of Clostridium Difficile Toxin by Real Time Cell Analysis In a recent paper published in the Journal of … Continued

Vivo Biosciences, ACEA Biosciences, and Roche to develop new xCELLigence System assays for stem cell and cancer research

Penzberg, Germany, October 6, 2010 ACEA Biosciences Inc. (San Diego, CA) and Vivo Biosciences Inc. (Birmingham, AL, US) announced that … Continued

Roche’s new RTCA Cardio Instrument for label-free functional cardiomyocyte toxicity testing

Penzberg, Germany , September 28, 2010 Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the RTCA Cardio … Continued

Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate to Evaluate iCell Cardiomyocytes on the xCELLigence System

Penzberg, Germany , September 16, 2010 Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate to Evaluate iCell Cardiomyocytes … Continued

The xCELLigence RTCA Cardio System

Cellular Dynamics International (CDI) announced today their partnership with ACEA Biosciences to bring early and accurate prediction of potential cardiotoxic … Continued

ACEA Biosciences, Inc., announces a major breakthrough in cardiotoxicity testing and limited-time free-access to customers

San Diego, CA June 18, 2010 ACEA Biosciences, Inc., with headquarters in San Diego, CA, is pleased to announce the … Continued

RTCA Cardiotoxicity testing system

ACEA Biosciences, Inc., with headquarters in San Diego, CA, is pleased to announce the early availability of its unique RTCA … Continued

the Early Detection of Hepatic Cytotoxicity

Reducing Animal Testing: Real-time Cell Analysis with Roche´s xCELLigence System for the Early Detection of Hepatic Cytotoxicity The 3Rs concept … Continued